OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
Zeren Sun, Lanjie Li, Bingxin Zhai, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4916-4935
Closed Access | Times Cited: 8
Zeren Sun, Lanjie Li, Bingxin Zhai, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4916-4935
Closed Access | Times Cited: 8
Showing 8 citing articles:
Recent advances in c-Met-based dual inhibitors in the treatment of cancers
Fanqi Jin, Yi‐Han Lin, Yuan Weidong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116477-116477
Closed Access | Times Cited: 12
Fanqi Jin, Yi‐Han Lin, Yuan Weidong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116477-116477
Closed Access | Times Cited: 12
Discovery of Noncovalent Diaminopyrimidine-based Inhibitors for Glioblastoma via a Dual FAK/DNA Targeting Strategy
Yi Wei, Xiaoling He, Zhiwu Long, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117288-117288
Closed Access | Times Cited: 1
Yi Wei, Xiaoling He, Zhiwu Long, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117288-117288
Closed Access | Times Cited: 1
Recent Progress in Poly(ADP–Ribose) Polymerase‐1 Inhibitors for Application in Cancer
Anuradha Mehra, Sayemul Islam, Rekha Sangwan
ChemistrySelect (2025) Vol. 10, Iss. 1
Closed Access
Anuradha Mehra, Sayemul Islam, Rekha Sangwan
ChemistrySelect (2025) Vol. 10, Iss. 1
Closed Access
Pharmacophore screening, molecular docking, and MD simulations for identification of VEGFR-2 and c-Met potential dual inhibitors
Junmin Dong, Xiaohua Hao
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Junmin Dong, Xiaohua Hao
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib
Sanaa Musa, Noor Amara, Adan Selawi, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2479-2479
Open Access | Times Cited: 2
Sanaa Musa, Noor Amara, Adan Selawi, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2479-2479
Open Access | Times Cited: 2
Nitro-fatty acids: promising agents for the development of new cancer therapeutics
Jessica Roos, Georg Manolikakes, Uwe Schlomann, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 11, pp. 1061-1080
Open Access | Times Cited: 2
Jessica Roos, Georg Manolikakes, Uwe Schlomann, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 11, pp. 1061-1080
Open Access | Times Cited: 2
Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA
Zhikun Liu, Shining Mao, Lumei Dai, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117936-117936
Closed Access
Zhikun Liu, Shining Mao, Lumei Dai, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117936-117936
Closed Access
Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges
Anshul Mishra, Amandeep Thakur, Ram Lal Sharma, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 11, pp. 1355-1381
Closed Access
Anshul Mishra, Amandeep Thakur, Ram Lal Sharma, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 11, pp. 1355-1381
Closed Access
